Gene therapy for neurometabolic dis- orders

Details for Australian Patent Application No. 2006243776 (hide)

Owner Genzyme Corporation

Inventors Stewart, Gregory R.; Dodge, James; Passini, Marco A.

Agent Davies Collison Cave

Pub. Number AU-A-2006243776

PCT Pub. Number WO2006/119458

Priority 60/677,057 02.05.05 US; 60/685,808 31.05.05 US

Filing date 2 May 2006

Wipo publication date 9 November 2006

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/119458 Priority application(s): WO2006/119458

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006243782-Predicting treatment response in cancer subjects

2006243758-Direct Electric Resistance Liquid Heater